Back to search

Article

Exon-Skipping Antisense Oligonucleotides for H3.3K27M-Altered Diffuse Midline Glioma Therapy

2026-04-04

Abstract excerpt

<h4>ABSTRACT</h4> Diffuse midline gliomas (DMGs) are a deadly class of pediatric high-grade brain cancers. Approximately 80% of pontine DMGs feature a dominant, somatic, heterozygous point mutation in the non-canonical histone H3.3-coding gene H3-3A . This dominant-negative mutation replaces lysine 27 with methionine (K27M) and prevents global K27 di- and tri-methylation of all wild-type histone H3 proteins. We...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
660b3d19-bf04-524a-8d57-088128dec6c1
DOI
10.64898/2026.04.03.715131
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exon-Skipping Antisense Oligonucleotides for H3.3K27M-Altered Diffuse Midline Glioma TherapyDOI 10.64898/2026.04.03.715131
Select a neighboring publication to make it the new centre.